Annabelle Bertin

Title: Annabelle Bertin: Innovator in Dendritic Chelated Compounds

Introduction

Annabelle Bertin is a notable inventor based in Strasbourg, France. She has made significant contributions to the field of pharmacy, particularly in medical imaging. Her innovative work focuses on dendritic chelated compounds, which have important applications in pharmaceutical compositions.

Latest Patents

Annabelle Bertin holds a patent for her invention titled "Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same." This invention relates to dendritic chelated compounds and methods for producing them. The compounds are characterized by a specific formula that includes various components such as magnetic markers, chelating agents, and therapeutic activity groups. The invention is particularly relevant in the field of pharmacy, enhancing capabilities in medical imaging.

Career Highlights

Throughout her career, Annabelle has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Louis Pasteur. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Annabelle has collaborated with notable colleagues, including Delphine Felder-Flesch and Jérôme Steibel. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Annabelle Bertin is a pioneering inventor whose work in dendritic chelated compounds has the potential to transform medical imaging. Her contributions to the field of pharmacy highlight the importance of innovation in advancing healthcare solutions.